The analysis of hospital discharges for benign neoplasm of the colon, rectum, and anus in 2023 reveals significant variations among countries. Australia had the highest discharges at 6.11k, closely followed by the Netherlands and Belgium. Noteworthy decreases were observed in Sweden and Israel, while New Zealand registered a notable increase of 2.51%. Overall, countries showed mixed trends with moderate fluctuations in discharge rates over the past year.
Looking towards the future, potential trends to watch include the ongoing advancement in preventive healthcare leading to possible reductions in discharge rates. Additionally, increased adoption of non-invasive treatments could alter current discharge dynamics across countries.
Top countries in Hospital Discharges for Benign Neoplasm of Colon, Rectum and Anus by Country
# | 10 Countries | Units (Hospital Discharges) | Last Year | YoY | 5-years CAGR | |
---|---|---|---|---|---|---|
1 | 1 Australia | 6,110 | 2023 | +0.56% | -0.78% | View data |
2 | 2 Netherlands | 4,600 | 2023 | +4.42% | +0.25% | View data |
3 | 3 Belgium | 4,050 | 2023 | +5.19% | +0.87% | View data |
4 | 4 Austria | 3,530 | 2023 | +4.2% | -0.12% | View data |
5 | 5 Czech Republic | 2,930 | 2023 | +2.41% | -1.32% | View data |
6 | 6 Canada | 2,700 | 2023 | +2.51% | -0.9% | View data |
7 | 7 Finland | 1,090 | 2023 | -1.01% | -0.13% | View data |
8 | 8 Slovakia | 994 | 2023 | +6.66% | +0.73% | View data |
9 | 9 Israel | 697 | 2023 | +2.65% | -1.79% | View data |
10 | 10 Ireland | 493 | 2023 | +6.02% | -0.32% | View data |